The R PATH randomized trial of the Hypertension Canada Professional Certification

The RxPATH randomized trial of the Hypertension Canada Professional Certification Program: A novel implementation strategy for hypertension guidelines Ross T. [...] Canada Background/Rationale: Results: • We enrolled 890 patients from 61 pharmacies • Uptake of guidelines into clinical practice is poor (including 104 pharmacists) • We designed an online educational program for Table 1 Demographics primary care clinicians, based upon the 2020 Control Treatment Control - Overall Hypertension Canada Guidelines Treatment(N = 235) (N = 344) (N = 311) (N = 890) • Th. [...] 4 Phases, each 3 months in duration Int = Intervention Phase Ctrl – Control Phase Primary Outcome: F-up = Follow-up of last patients 5.48 mmHg SBP reduction • Setting: Community pharmacies in Alberta, Canada • Population: • Patients with poorly controlled hypertension: • Patient satisfaction using the Consultant BP>140/90 mmHg or >130/80 mmHg Satisfaction Questionnaire was high at 76 (of 90 (diabe. [...] including prescribing, so results might not be generalizable • Selection bias for pharmacists interested in hypertension and contamination of the control group* • Short follow-up of only 3 months* • The COVID-19 pandemic (we started in September Hypertension Canada Professional Certification Program 2020)*: • challenges for staffing and workloads in pharmacies Funding Sources: • difficult for phar. [...] Servier Alberta Innovation Health Fund, a partnership • site dropouts between Servier Canada Inc., the University Hospital • patient reluctance to present for follow-up visits Foundation and the Alberta Ministry of Jobs, Economy * may have also decreased intervention effect and Innovation 2.